Alternative Data for iRhythm Technologies
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 72 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 93,000 | Sign up | Sign up | Sign up |
| Employee Rating | 58 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,970 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,558 | Sign up | Sign up | Sign up |
| X Followers | 2,616 | Sign up | Sign up | Sign up |
| X Mentions | 20 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 43 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,795 | Sign up | Sign up | Sign up |
About iRhythm Technologies
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.
| Price | $126.95 |
| Target Price | Sign up |
| Volume | 943,520 |
| Market Cap | $4.07B |
| Year Range | $125.85 - $189.25 |
| Dividend Yield | 0% |
| Analyst Rating | 80% buy |
| Industry | Medical & Dental Instruments |
In the news
iRhythm Holdings, Inc. (IRTC) Q4 2025 Earnings Call TranscriptFebruary 19 - SeekingAlpha |
|
iRhythm Technologies Q4 Earnings Call HighlightsFebruary 19 - MarketBeat |
|
iRhythm Technologies Q4 Adj. EPS $0.29 Beats $0.03 Estimate, Sales $208.890M Beat $201.592M EstimateFebruary 19 - Benzinga |
|
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law FirmJanuary 28 - GlobeNewswire |
|
 |
iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 12 - SeekingAlpha |
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 12 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 209M | 61M | 148M | 5.6M | 2.3M | 0.290 |
| Q3 '25 | 193M | 56M | 137M | -5.2M | 2.4M | 0.060 |
| Q2 '25 | 187M | 54M | 133M | -14M | -5.4M | -0.320 |
| Q1 '25 | 159M | 49M | 109M | -31M | -21M | -0.950 |
| Q4 '24 | 164M | 49M | 115M | -1.3M | 8.7M | 0.010 |
Insider Transactions View All
| Shrishrimal Sumi filed to sell 42,848 shares at $128.4. March 3 '26 |
| Shrishrimal Sumi filed to sell 43,754 shares at $128.4. March 3 '26 |
| Shrishrimal Sumi filed to sell 41,870 shares at $128.4. March 3 '26 |
| Wilson Daniel G. filed to sell 36,921 shares at $128.5. March 3 '26 |
| Wilson Daniel G. filed to sell 38,300 shares at $128.4. March 3 '26 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
NovoCureNVCR |
$14.23 6% | 39 |
 |
DanaherDHR |
$202 1.3% | 52 |
 |
Envista HoldingsNVST |
$27.93 1.8% | 51 |
 |
Baxter InternationalBAX |
$18.6 2.3% | 45 |
 |
NeogenNEOG |
$10.69 1% | 36 |
Read more about iRhythm Technologies (IRTC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - iRhythm Technologies
The Market Cap of iRhythm Technologies is $4.07B.
Currently, the price of one share of iRhythm Technologies stock is $126.95.
The IRTC stock price chart above provides a comprehensive visual representation of iRhythm Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling iRhythm Technologies shares. Our platform offers an up-to-date IRTC stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, iRhythm Technologies (IRTC) does not offer dividends to its shareholders. Investors interested in iRhythm Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of iRhythm Technologies are NovoCure, Danaher, Envista Holdings, Baxter International, and Neogen.
